Novasep Belgium Overview
- Founded
- 2000
- Status
- Acquired/Merged
- Employees
- 400
- Latest Deal Type
- M&A
- Financing Rounds
- 3
- Investments
- 1
Novasep Belgium General Information
Description
Manufacturer of biopharmaceutical products based in Gosselies, Belgium. The company develops recombinant proteins, subunit and live attenuated vaccines, monoclonal antibodies and viral vectors.
Contact Information
Formerly Known As
Henogen
Ownership Status
Acquired/Merged
Financing Status
Formerly PE-Backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Pharmaceuticals
Acquirer
Primary Office
- Rue Clément Ader 16
- 6041 Gosselies
- Belgium
+32 071 00 00 00
Novasep Belgium Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
This information is available in the PitchBook Platform. To explore Novasep Belgium‘s full profile, request access.
Request a free trialNovasep Belgium Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %ile
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trialNovasep Belgium Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
This information is available in the PitchBook Platform. To explore Novasep Belgium‘s full profile, request access.
Request a free trialNovasep Belgium Acquisitions (1)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| 00 0000000 | 02-Jul-2003 | 000000000000000000 | Biotechnology |